CDH5 and breast cancer: Overexpression of S1PR1 in breast cancer prevents the VM formation by inducing VE-cadherin phosphorylation on tyrosine 731, leading to disruption of the VE-cadherin/β-catenin complex and, thus, a reduction in tumor growth [85].